GLF
NVO

Groupe la Francaise’s Novo Nordisk NVO Stock Holding History

Groupe la Francaise’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.21K Buy
+100
New +$4.74K ﹤0.01% 442
2025
Q4 		– Sell
-949
Closed -$7.06K – 672
2025
Q3 		$7.06K Buy
+949
New +$55.5K ﹤0.01% 601

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Groupe la Francaise's NVO Position: Q1 2026 in Review

Groupe la Francaise opened a new position in Novo Nordisk (NVO) in Q1 2026: 100 shares worth $3.21K. The stake represents ﹤0.01% of the portfolio and ranks #442 among its holdings. This is a return to the name: Groupe la Francaise previously reported a position in NVO as recently as Q3 2025.

Groupe la Francaise first reported a position in NVO in Q3 2025 and has held it in 2 quarters since. The position peaked at $7.06K in Q3 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Groupe la Francaise held 100 shares of Novo Nordisk worth $3.21K as of Q1 2026.
  • Novo Nordisk was a new Groupe la Francaise position in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Groupe la Francaise's portfolio in Q1 2026, its #442 holding.
  • Groupe la Francaise first reported a position in Novo Nordisk in Q3 2025 and has held it in 2 quarters since.
  • Groupe la Francaise's Novo Nordisk position peaked at $7.06K in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.